Related Experiment Video
Updated: Mar 29, 2026

07:31
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
10.8K
[THE INFLUENCE OF ABDOMINAL OBESITY ON LEFT VENTRICULAR MYOCARDIALREMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION]
Klinicheskaia Meditsina
|November 25, 2015
Summary
Obesity influences arterial hypertension (AH) complications. Abdominal obesity is linked to eccentric left ventricular hypertrophy and coronary insufficiency in hypertensive patients.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Context:
- Arterial hypertension (AH) is a prevalent condition.
- Obesity, particularly abdominal obesity, is a growing health concern.
- Understanding the impact of obesity on AH comorbidities is crucial for patient management.
Purpose:
- To investigate the relationship between obesity and clinical/instrumental characteristics in patients with Grade II hypertensive disease (HD).
- To compare left ventricular (LV) hypertrophy patterns and cardiac issues between hypertensive patients with normal weight and those with abdominal obesity.
Summary:
- A study compared 79 patients with Grade II HD and normal weight (Group I) to 61 with Grade II HD and abdominal obesity (Group 2).
- Both groups exhibited high rates of left ventricular hypertrophy (59.2% in Group I, 73.8% in Group II).
- Concentric LV hypertrophy was more common in Group I, while eccentric hypertrophy predominated in Group 2. Relative coronary insufficiency was more frequent in Group 2, and cardiac rhythm disturbances were more common in Group I.
Impact:
- Abdominal obesity is associated with specific patterns of left ventricular hypertrophy (eccentric) in hypertensive patients.
- Hypertensive patients with abdominal obesity face a higher risk of relative coronary insufficiency.
- These findings highlight the importance of weight management in controlling AH and its cardiovascular complications.
Related Concept Videos
Heart Failure II: Pathophysiology
1.4K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Aortic Regurgitation III: Medical Management
549
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
549
Cardiomyopathy III: Hypertrophic Cardiomyopathy
697
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
697
Mitral Regurgitation I: Introduction
1.0K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.0K
Pathophysiology of Heart Failure
4.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K

